ACXPNasdaq CM
Acurx Pharmaceuticals, Inc.
1.41+0.71%1d
Data as of Aug 25, 2026 · end-of-day snapshot
Volume signal tier—
Alert levelinsufficient_liquidity
Tier and alert level are a summary. Unlock ACXP to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.
−2.08%, downReturn · 1w
−1.40%, downReturn · 1m
−29.15%, downReturn · 3m
−73.44%, downReturn · 1y
−83.09%, well below its 52-week highvs 52-week high
Technicals
Technical readings
The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.
DowntrendSee the full setup read: unlock ACXP
Automated read
Price is trading below its key moving averages: the mid-term picture reads as a downtrend. RSI is currently 45.
RSI (14)45.19Neutral
MACD / signal-0.02 / -0.02, caution readingBelow signal line
SMA 501.50, caution readingPrice below
SMA 2002.54, caution readingPrice below
EMA 201.47, caution readingPrice below
ADX (14)21.45Firming
+DI / −DI28.52 / 15.90, favorable reading+DI leading
ATR (14)0.14, flagged reading9.9% of price — elevated daily swings
Stochastic %K19.72, flagged readingOversold zone
Bollinger bands (20)1.34 – 1.59Inside bands
ROC (10)-4.08, caution readingNegative over 10 sessions
Trend / momentum impulseBoth falling, caution impulse readingTrend and momentum agree
Readings as of Aug 25, 2026 · end-of-day snapshot
Full analysis
What unlocking ACXP reveals
Sample preview: figures are illustrative.
Company & theme write-up
Signal history
AI narrative
Catalysts & risks
Accumulation read
Unlock
ACXP: full analysis
AI narrative · signals & history · social sentiment · full fundamentals
$9.90 USD
one-time · 30-day access
- Unlocked in about 60 seconds
- 30-day access
- No account needed
Analyzing a few names? Get 5 for $25.00 or 15 for $49.00: one-time, 30 days for the whole pack, swaps included.
Free weekly sample report
Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.
Earnings
When does Acurx Pharmaceuticals, Inc. report earnings?
Acurx Pharmaceuticals, Inc. (ACXP) is scheduled to report earnings on Nov 11, 2026.
The date is confirmed rather than estimated, though companies do occasionally reschedule.
Data as of Aug 26, 2026
See who else reports soonNeed the raw data?Get ACXP + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset $9.90one-time Unlock ACXP